10:01 AM EST - Medicure Inc. : Has submitted an application to the U.S. Food and Drug Administration (FDA) for the introduction of a new "bolus vial" product format for AGGRASTAT (tirofiban HCl). Medicure Inc.
shares V.MPH are trading up $0.16 at $4.97.
